Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2012.11209.x/fullpdf
Reference57 articles.
1. Advances in the treatment of moderate-to-severe plaque psoriasis;Herrier;Am J Health Syst Pharm,2011
2. Adalimumab induction therapy for Crohn’s disease previously treated with infliximab; a randomised trial;Sandborn;Ann Intern Med,2007
3. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF antagonist therapy in clinical practice;Bombardieri;Rheumatology (Oxford),2007
4. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review;Rubbert-Roth;Arthritis Res Ther,2009
5. Abbot Laboratories Ltd Humira: summary of product characteristics http://www.medicines.org.uk/emc/medicine/21201/SPC
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sequential interleukin-17 inhibitors for moderate-to-severe plaque psoriasis who have an IL-17 inhibitors failure in a resource limited country: An economic evaluation;PLOS ONE;2024-08-09
2. Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety;Pharmacology & Therapeutics;2022-01
3. Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry;Dermatology and Therapy;2021-11-25
4. The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study;TURKDERM;2021-10-01
5. SnapshotDx Quiz: August 2021;Journal of Investigative Dermatology;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3